ASTS
AST SpaceMobile, Inc.
ASTS has a slight edge over HIMX overall, supported by stronger valuation and stronger fundamentals.
HIMX
Himax Technologies, Inc.
HIMX has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HIMX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
HIMX's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
HIMX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.5x | $0.89 | -90% |
| Fair | 16x | $3.12 | -65% |
| Expensive | 44x | $8.79 | -1.8% |
| Current | 45x | $8.96 | — |
Historical ranges are pointers, not guarantees.
HIMX's PE is in its expensive range at 45x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
HIMX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HIMX's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
HIMX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.20 | -52% |
| Q1 2026 | $0.18 | -63% |
| Q4 2025 | $0.25 | -46% |
| Q3 2025 | $0.35 | -22% |
| Q2 2025 | $0.42 | -4.5% |
| Q1 2025 | $0.49 | +81% |
| Q4 2024 | $0.46 | +64% |
| Q3 2024 | $0.45 | +15% |
HIMX has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over HIMX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
HIMX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $227.4M | +5.9% |
| Q1 2026 | $199M | -7.5% |
| Q4 2025 | $203.1M | -14% |
| Q3 2025 | $196.7M | -12% |
| Q2 2025 | $214.8M | -10% |
| Q1 2025 | $215.1M | +3.7% |
| Q4 2024 | $237.2M | +4.2% |
| Q3 2024 | $222.4M | -6.8% |
HIMX's revenue is recovering but still below its 2021 peak: $227M last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | +2.4 points |
| Q1 2026 | 5.1% | -4.1 points |
| Q4 2025 | 3.4% | -6.4 points |
| Q3 2025 | -0.3% | -2.9 points |
| Q2 2025 | 8.4% | -3.8 points |
| Q1 2025 | 9.2% | +4.4 points |
| Q4 2024 | 9.7% | +2.4 points |
| Q3 2024 | 2.6% | -2 points |
HIMX has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
HIMX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $13.2M | -76% |
| Q1 2026 | $1.2M | -98% |
| Q4 2025 | $12.7M | -61% |
| Q3 2025 | $55K | +$5.8M |
| Q2 2025 | $55.9M | +150% |
| Q1 2025 | $50.8M | -5.8% |
| Q4 2024 | $32.2M | -41% |
| Q3 2024 | -$5.7M | -143% |
HIMX has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.4x | Net Cash |
| Q1 2026 | -3.4x | Net Cash |
| Q4 2025 | -2.8x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 3.1x | Elevated |
| Q3 2024 | 3.7x | Elevated |
HIMX has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
HIMX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.7 | Neutral |
| Stochastic | 12.8 | Oversold |
HIMX's weekly RSI is 37 (neutral) and its Stochastic is 13 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
HIMX PE vs Technology Sector
| Metric | HIMX | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 28x | 62% above |
| PE % | 83 | 35 | 48 pts above |
HIMX is trading at 45x earnings, a 62% premium to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
HIMX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.8 | 24% below |
| 20 week MA | $13.0 | 31% below |
| 50 week MA | $12.0 | 26% below |
| 100 week MA | $10.3 | 13% below |
| 200 week MA | $8.34 | 7.4% above |
HIMX has fallen below most of its moving averages, though it's still 7.4% above its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
HIMX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.50 | $6.76 | +170% |
| 2021 | $6.76 | $12.5 | +84% |
| 2022 | $12.5 | $6.72 | -46% |
| 2023 | $6.72 | $6.07 | -9.7% |
| 2024 | $6.07 | $7.96 | +31% |
| 2025 | $7.96 | $8.35 | +4.9% |
| 2026 YTD | $8.35 | $8.96 | +7.3% |
HIMX has the edge over ASTS on returns for 2026, with the stronger performance.